{
    "info": {
        "nct_id": "NCT06026254",
        "official_title": "Rollover Study to Continue IMSA101 Treatments in Patients With Advanced Treatment-Refractory Malignancies Previously Enrolled in the Phase I/IIA Safety and Efficacy Study of IMSA101",
        "inclusion_criteria": "1. Signed informed consent and mental capability to understand the informed consent\n2. Currently enrolled in parent protocol IMSA101-101 and is receiving IMSA101 treatment\n3. Deriving clinical benefit from study treatment, as determined by the investigator\n4. Must have fulfilled all required assessments in parent protocol IMSA101-101\n5. Male and female patients with reproductive potential must agree to use two forms of highly effective contraception throughout the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Permanently discontinued from IMSA101 treatment in parent protocol IMSA101-101 for any reason other than enrollment in the rollover study\n2. Failure to meet the criteria specified in parent protocol IMSA101-101 for continued study treatment",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Currently enrolled in parent protocol IMSA101-101 and is receiving IMSA101 treatment",
            "criterions": [
                {
                    "exact_snippets": "Currently enrolled in parent protocol IMSA101-101",
                    "criterion": "enrollment in parent protocol IMSA101-101",
                    "requirements": [
                        {
                            "requirement_type": "enrollment status",
                            "expected_value": "currently enrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "is receiving IMSA101 treatment",
                    "criterion": "IMSA101 treatment",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "receiving"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Signed informed consent and mental capability to understand the informed consent",
            "criterions": [
                {
                    "exact_snippets": "Signed informed consent",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "signed",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "mental capability to understand the informed consent",
                    "criterion": "mental capability to understand informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Must have fulfilled all required assessments in parent protocol IMSA101-101",
            "criterions": [
                {
                    "exact_snippets": "fulfilled all required assessments in parent protocol IMSA101-101",
                    "criterion": "required assessments in parent protocol IMSA101-101",
                    "requirements": [
                        {
                            "requirement_type": "completion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Deriving clinical benefit from study treatment, as determined by the investigator",
            "criterions": [
                {
                    "exact_snippets": "Deriving clinical benefit from study treatment, as determined by the investigator",
                    "criterion": "clinical benefit from study treatment",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "determined by",
                            "expected_value": "investigator"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Male and female patients with reproductive potential must agree to use two forms of highly effective contraception throughout the study",
            "criterions": [
                {
                    "exact_snippets": "Male and female patients with reproductive potential",
                    "criterion": "reproductive potential",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must agree to use two forms of highly effective contraception throughout the study",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "number of forms",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "forms"
                            }
                        },
                        {
                            "requirement_type": "effectiveness",
                            "expected_value": "highly effective"
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "throughout the study"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "1. Permanently discontinued from IMSA101 treatment in parent protocol IMSA101-101 for any reason other than enrollment in the rollover study",
            "criterions": [
                {
                    "exact_snippets": "Permanently discontinued from IMSA101 treatment in parent protocol IMSA101-101 for any reason other than enrollment in the rollover study",
                    "criterion": "IMSA101 treatment discontinuation in parent protocol IMSA101-101",
                    "requirements": [
                        {
                            "requirement_type": "discontinuation status",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "reason for discontinuation",
                            "expected_value": "any reason other than enrollment in the rollover study"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Failure to meet the criteria specified in parent protocol IMSA101-101 for continued study treatment",
            "criterions": [
                {
                    "exact_snippets": "Failure to meet the criteria specified in parent protocol IMSA101-101 for continued study treatment",
                    "criterion": "criteria specified in parent protocol IMSA101-101 for continued study treatment",
                    "requirements": [
                        {
                            "requirement_type": "fulfillment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}